Gurská Soňa Ph.D.

Journals

SUAREZ, A., K. CHAVEZ, P. MARTINEZ, J. BUBIS, Z. BLANCO, H. RAMIREZ, J. GARMENDIA, J. DE SANCTIS, S. GURSKÁ, P. DŽUBÁK, M. HAJDÚCH, J. CHARRIS
New 1,2,3-Triazole Hybrids as Anticancer Agents: Design, Synthesis, Characterization, and In Silico Studies. ChemMedChem. 2026, 21(15), e70425, ISSN: 1860-7179 , PMID: 42552512,  PDF.
HEBENBROCK, M., S. GURSKÁ, K. BOGDANOVÁ, K. RESOVA, M. KOLÁŘ, F. BOISTEN, M. HAJDÚCH, P. DŽUBÁK, J. MULLER
Cytotoxicity and antimicrobial activity of platinum(II) complexes based on the ligand precursor 2-phenyl-6-(1,2,3-triazol-4-yl)pyridine - influence of substituent and ancillary ligand on selectivity and activity. Zeitschrift für Naturforschung. C, Journal of biosciences. 2026, ISSN: 0939-5075, PMID: 42214343,  PDF.
BACHOŘÍK, J., I. FRYDRYCH, S. GURSKÁ, S. DOSTAL, J. POKORNÝ, M. HAJDÚCH, M. URBAN
New Synthetic Approach to C‑30 Ethers, Esters, and Amines of Betulin Using the Mitsunobu Reaction and Biological Evaluation of the Products. ACS Omega. 2026, 11(16), 24564-24579, ISSN: 2470-1343, PMID: 42077890,  PDF.

Books & book chapters

GURSKÁ, S.
Analysis of cytotoxicity by tetrazolium salt reduction test , 1.vyd., Olomouc, Palacky University, 2021, 10, 67-72, Dedication: LO1304, ISBN: 978-80-244-6049-9,

Intellectual property

RNA ISOLATION KIT (Džubák)

Utility Model: CZ 35067. Granted: 18.5.2021. Ownership: Palacky University, Olomouc. Inventors: Džubák Petr, Hajdúch Marián, Gurská Soňa, Koudeláková Vladimíra, Jaworek Hana.

Status: Available

Master mentorship

Synek Vojtěch

Development of the assay for measurement of the CA activity and its implementation into HTS

Stav: Absolvoval od 2018 do 2020.
Dostálová Kristýna

Cell-based assays for high-throughput screening in drug discovery

Stav: Absolvoval od 2014 do 2016.
Voltemarová Tereza

Cytotoxicity profiling of new potentially bioactive compounds using high throughput screening (HTS)

Stav: Absolvoval od 2019 do 2021.

Bachelor mentorship

Jamborová Petra

Establishment and characterization of anticancer drug resistant leukemic cell lines

Stav: Probíhající od 2023.
Synek Vojtěch

Cytotoxicity tests for high-throughput drug discovery

Stav: Absolvoval od 2014 do 2018.
Zabáková Dominika

Analysis of the cytotoxic effects of new chemical substances in HTS conditions

Stav: Absolvoval od 2021 do 2021.

Open positions

Projekt: Drug repurposing for treatment and prevention of diseases
Vedoucí: Hajdúch Marián M.D., Ph.D., Gurská Soňa Ph.D.
K dispozici: 2
Určeno pro: Doktorské studium